This product has stimulating results

Perfuzia Medical Inc. and partners this month were awarded $200,000 by the state to take to clinical testing a device company founder Sagi Brink-Danan is holding to stimulate blood flow to wounded tissue. The technology could potentially ease the suffering of thousands of people with chronic tissue wounds like burns and bed sores. It was developed by Brink-Danan and fellow Israeli ex-pat Schai Schubert. The prototype the Providence company is testing is about the size of a small cellphone, flexible, and can run for about a week on a single battery charge. / PBN PHOTO/HILARY ROSENTHAL
Perfuzia Medical Inc. and partners this month were awarded $200,000 by the state to take to clinical testing a device company founder Sagi Brink-Danan is holding to stimulate blood flow to wounded tissue. The technology could potentially ease the suffering of thousands of people with chronic tissue wounds like burns and bed sores. It was developed by Brink-Danan and fellow Israeli ex-pat Schai Schubert. The prototype the Providence company is testing is about the size of a small cellphone, flexible, and can run for about a week on a single battery charge. / PBN PHOTO/HILARY ROSENTHAL

Perfuzia Medical Inc. and partners this month were awarded $200,000 by the state to take to clinical testing a device company founder Sagi Brink-Danan is holding to stimulate blood flow to wounded tissue. The technology could potentially ease the suffering of thousands of people with chronic tissue wounds like burns and bed sores. It was developed by Brink-Danan and fellow Israeli ex-pat Schai Schubert. The prototype the Providence company is testing is about the size of a small cellphone, flexible, and can run for about a week on a single battery charge.

No posts to display